77 related articles for article (PubMed ID: 22835434)
1. Flow cytometry of v-Abl transformed pre-B cells heterogeneous in ectopic expression levels reveals Ras dose-response.
Peacock RW; Lawhorn IE; Ferreira JP; Wang CL
J Immunol Methods; 2012 Oct; 384(1-2):177-83. PubMed ID: 22835434
[TBL] [Abstract][Full Text] [Related]
2. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
3. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
4. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
[TBL] [Abstract][Full Text] [Related]
5. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
Warren D; Griffin DS; Mainville C; Rosenberg N
J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
[TBL] [Abstract][Full Text] [Related]
6. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
8. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
9. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
Parmar K; Rosenberg N
J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
[TBL] [Abstract][Full Text] [Related]
10. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
13. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
14. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
15. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
17. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
Yi CR; Rosenberg N
J Virol; 2007 Sep; 81(17):9461-8. PubMed ID: 17596313
[TBL] [Abstract][Full Text] [Related]
18. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
20. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.
Mathiasen DP; Egebjerg C; Andersen SH; Rafn B; Puustinen P; Khanna A; Daugaard M; Valo E; Tuomela S; Bøttzauw T; Nielsen CF; Willumsen BM; Hautaniemi S; Lahesmaa R; Westermarck J; Jäättelä M; Kallunki T
Oncogene; 2012 Jan; 31(3):390-401. PubMed ID: 21706057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
